Co-Dx
Highly Engaged Employees

Q: What is Co-Dx's official website?

Co-Dx's official website is www.co-dx.com

Q: What industry does Co-Dx belong to?

Co-Dx is in the industry of: Manufacturing , Software , Pharmaceuticals

Q: What technology does Co-Dx use?

Some of the popular technologies that Co-Dx uses are: WooCommerce, WordPress.org, PHP, DoubleClick

Q: Who is the CTO of Co-Dx?

Co-Dx's CTO is Christopher Thurston

Q: How do I contact Co-Dx?

Co-Dx contact info: Phone number: (801) 438-1036 Website: www.co-dx.com

Q: What does Co-Dx do?

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-c... are and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. Read More

Q: What are Co-Dx social media links?

Co-Dx Linkedin page Co-Dx Twitter page Co-Dx Facebook page

Q: Is Co-Dx a public company?

Yes, Co-Dx is a public company and is traded under the symbol CODX

Manufacturing · Utah, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

2401 S Foothill Dr Ste D, Salt Lake City...

Phone Number

(801) 438-1036

Website

www.co-dx.com

Revenue

<$5 Million

Stock Symbol

CODX

Industry

Medical Laboratories & Imaging Centers

ZI Rank: 1

Signal Type

Dec

Jan

Feb

Mar

Apr

May

ZI Rank

About Co-Dx

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2Read more

Is this data correct?

View contact profiles from Co-Dx

Popular SearchesCo-diagnostics IncCo - Diagnostics IncCo-DiagnosticsCo Diagnostics IncCo - DiagnosticsSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: CODXShow more

Co-Dx Org Chart

Dwight Egan

Chief Executive Officer

Phone

Christopher Thursto...

Chief Technology Officer

Phone

Richard Abbott

President

Phone

Ivory Chang

Chief Regulatory Affairs Officer

Phone

Get the full picture

Kenneth Bramwell

Deputy Chief Science Officer

Phone

Get the full picture

Is Co-Dx your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Check if Co-Dx has recently received funding, and reach out quickly before it becomes old news!

Click to see if Co-Dx had a recent Job posting/layoffs

Website visits: Recent activity has been detected on your website

Earning: See what the market has to say on Co-Dx recently announced quarterly report

Product Launch: Get notified when Co-Dx launches new products

Check out if Co-Dx is spiking on competitors!

Congratulate Masked Content for being promoted to Masked Content at Co-Dx

Co-Dx, which may be a good buyer, showed buying intent in Masked Content Topic

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Funding: Get notified immidiatlly once Co-Dx has new funding data

Recommended Actions

Find VP level buyers at Co-Dx

Find 3 more new buyers

View Email Formats for Co-Dx

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Co-Dx is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Co-Dx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Co-Dx.

Co-Dx financials insights

Gather financial insights about Co-Dx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2016

Debt

$750K

2017

Stock Offering

$7.1M

2023

Grant

$2.3M

2026

Stock/Share Issuance

$3M

See All Co-Dx's Financials Insights

Co-Dx Tech Stack

A closer look at the technologies used by Co-Dx

PHP

See more technologies

Most Recent Scoops

Funding

Co-Dx has secured $3 million in funding from its Private Placement. Investors were not disclosed.

Funding

Facilities Relocation / Expansion

Co-Dx announced that its CoMira joint venture is progressing toward operational readiness, including finalizing a lease for a manufacturing facility in Saudi Arabia, as part of its strategy to expand across Saudi Arabia and 18 additional MENA markets.

Leasing, Corporate Strategy, Manufacturing Operations

Earnings

Co-Dx has reported total operating expenses of $50.6 million for the full year 2025, compared to $43.0 million in 2024, with the increase primarily driven by a non-cash impairment charge of approximately $18.9 million related to in-process research and development intangible assets; excluding this charge, operating expenses declined year-over-year.

Earnings, Research & Development, Finance

Earnings

Co-Dx has reported a net loss of $46.9 million, or $35.25 per share, for the full year 2025, compared to a net loss of $37.6 million, or $37.22 per share, in 2024, with Adjusted EBITDA improving to a loss of $28.0 million from a loss of $33.5 million in the prior year.

Earnings, Finance

Project

Product Development, Clinical Operations

See more scoops

Top Manufacturing Companies

Frequently Asked Questions Regarding Co-Dx

What is Co-Dx's stock symbol?

Co-Dx's stock symbol is CODX

What is Co-Dx's official website?

Co-Dx's official website is www.co-dx.com

What is Co-Dx's Revenue?

Co-Dx's revenue is <$5 Million

What is Co-Dx's SIC code?

Co-Dx's SIC: 28,283

What is Co-Dx's NAICS code?

Co-Dx's NAICS: 32,325

How many employees does Co-Dx have?

Co-Dx has 51-200 employees

What industry does Co-Dx belong to?

Co-Dx is in the industry of: Manufacturing, Software, Pharmaceuticals

What technology does Co-Dx use?

Some of the popular technologies that Co-Dx uses are: WooCommerce, WordPress.org, PHP, DoubleClick

Who is the CTO of Co-Dx?

Co-Dx's CTO is Christopher Thurston

How do I contact Co-Dx?

Co-Dx contact info: Phone number: (801) 438-1036 Website: www.co-dx.com

What does Co-Dx do?

What are Co-Dx social media links?

Co-Dx Linkedin page Co-Dx Twitter page Co-Dx Facebook page

Is Co-Dx a public company?

Yes, Co-Dx is a public company and is traded under the symbol CODX

See more information about Co-Dx

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.